Volume 23, Number 6—June 2017
Dispatch
Febrile Respiratory Illness Associated with Human Adenovirus Type 55 in South Korea Military, 2014–20161
Hongseok Yoo, Se Hun Gu, Jaehun Jung, Dong Hyun Song, Changgyo Yoon, Duck Jin Hong, Eun Young Lee, Woong Seog, Il-Ung Hwang, Daesang Lee, Seong Tae Jeong2
, and Kyungmin Huh2
, and Kyungmin Huh2
Table 2
Clinical characteristics of patients with or without identification of HAdV from respiratory specimens PCR, South Korea, 2014–2016*
| Clinical characteristic | Patients with HAdV, n = 447 | Patients with other virus or PCR negative for HAdV, n = 431 | OR (95% CI) | p value |
|---|---|---|---|---|
| Presenting symptoms | ||||
| Cough† | 423 (94.6) | 395 (91.9) | 1.56 (0.91–2.67) | 0.102 |
| Rhinorrhea‡ | 229 (51.3) | 192 (44.7) | 1.31 (1.00–1.71) | 0.047 |
| Sore throat§ | 286 (64.3) | 207 (48.1) | 1.94 (1.48–2.54) | <0.001 |
| Dyspnea¶ | 60 (13.5) | 41 (9.5) | 1.48 (0.97–2.25) | 0.070 |
| Diarrhea# | 125 (33.8) | 60 (17.2) | 2.46 (1.73–3.49) | <0.001 |
| Nausea/vomiting** |
115 (31.0) |
58 (16.6) |
2.25 (1.58–3.22) |
<0.001 |
| Pneumonia |
231 (51.7) |
250 (58.0) |
0.77 (0.59–1.01) |
0.060 |
| Hospitalization | 277 (62.0) | 270 (62.6) | 0.97 (0.74–1.28) | 0.836 |
| Intensive care | 70 (25.3) | 30 (11.1) | 2.71 (1.70–4.31) | <0.001 |
| Mechanical respiratory support | 25 (9.0) | 5 (1.9) | 5.26 (1.98–13.95) | <0.001 |
| Intubation | 8 (2.9) | 0 | NA | 0.005 |
| Death | 1 (0.4) | 0 | NA | 0.323 |
| Length of stay, d, mean (SD) | 12.6 (9.7) | 9.4 (5.0) | NA | <0.001 |
*Values are no. (%) except as indicated. HAdV, human adenovirus; NA, not available; OR, odds ratio.†n = 877.
‡n = 876.
§n = 875.
¶n = 876.
#n = 719.
**n = 720.
1Preliminary results from this study were presented at the Annual Spring Meeting of the Korean Society for Chemotherapy, April 21–22, Seoul, South Korea.
2These authors contributed equally to this article.
Page created: May 16, 2017
Page updated: May 16, 2017
Page reviewed: May 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.